| 英文名称 |
中文名称 |
CAS号 |
操作 |
| APG-1387 |
APG-1387 |
1570231-89-8 |
详细
|
| CDK9-IN-7 |
CDK9-IN-7 |
2369981-71-3 |
详细
|
| Azadirachtin |
印楝素 |
11141-17-6 |
详细
|
| 10058-F4 |
5-(4-乙基苯亚甲基)绕丹宁 (该产品不可在美国销售) |
403811-55-2 |
详细
|
| KSI-3716 |
KSI-3716 |
1151813-61-4 |
详细
|
| GSK-843 |
GSK-843 |
1601496-05-2 |
详细
|
| Domatinostat |
(2E)-N-(2-氨基苯基)-3-[1-[[4-(1-甲基-1H-吡唑-4-基)苯基]磺酰基]-1H-吡咯-3-基]-2-丙烯酰胺 |
910462-43-0 |
详细
|
| A-385358 |
A-385358 |
406228-55-5 |
详细
|
| Forodesine hydrochloride |
FORODESINE HYDROCHLORIDE |
284490-13-7 |
详细
|
| Forodesine |
7-[(2S,3S,4R,5R)-3,4-二羟基-5-(羟甲基)-2-吡咯烷基]-3,5-二氢-4H-吡咯并[3,2-D]嘧啶-4-酮 |
209799-67-7 |
详细
|
| NKP-1339 |
CS-2765 |
197723-00-5 |
详细
|
| Omigapil maleate |
TCH 346 MALEATE; CGP3466B; CGP-3466B; TCH346; TCH-346 |
200189-97-5 |
详细
|
| Trifluridine/tipiracil hydrochloride mixture |
TAS102 |
733030-01-8 |
详细
|
| Voreloxin Hydrochloride |
(3S-反式)-1,4-二氢-7-[3-甲氧基-4-(甲基氨基)-1-吡咯烷基]-4-氧代-1-(2-噻唑基)-1,8-萘啶-3-羧酸单盐酸盐 |
175519-16-1 |
详细
|
| Riviciclib hydrochloride |
P276-00 |
920113-03-7 |
详细
|
| PFI-1 |
PFI-1 (PF-6405761) |
1403764-72-6 |
详细
|
| INH1 |
N-[4-(2,4-二甲基苯基)-2-噻唑基]苯甲酰胺 |
313553-47-8 |
详细
|
| Mcl1-IN-1 |
2-[2-[(5-氯-8-羟基-7-喹啉基)(2-吡啶基氨基)甲基]苯氧基]乙酸 |
713492-66-1 |
详细
|
| MIM1 |
4-[[[2-(环己基亚氨基)-4-甲基-3(2H)-噻唑基]亚氨基]甲基]-1,2,3-苯三醇 |
509102-00-5 |
详细
|
| BV6 |
BV 6 |
1001600-56-1 |
详细
|
| Temozolomide |
替莫唑胺 |
85622-93-1 |
详细
|
| Cisplatin |
顺铂 |
15663-27-1 |
详细
|
| Prexasertib dihydrochloride |
CHK1抑制剂 |
1234015-54-3 |
详细
|
| Prexasertib dimesylate |
无中文名称 |
1234015-58-7 |
详细
|
| (R)-CR8 |
(2R)-2-[[9-异丙基-6-[[[4-(2-吡啶基)苯基]甲基]氨基]-9H-嘌呤-2-基]氨基]-1-丁醇 |
294646-77-8 |
详细
|
| (R)-CR8 trihydrochloride |
(R)-CR8 (trihydrochloride) |
1786438-30-9 |
详细
|
| OTS514 |
OTS514 |
1338540-63-8 |
详细
|
| OSU-T315 |
OSU-T315 |
2070015-22-2 |
详细
|
| RIPK1-IN-4 |
RIPK1-IN-4 |
1481641-08-0 |
详细
|
| WEHI-345 |
N-[2-[4-氨基-3-(4-甲基苯基)-1H-吡唑并[3,4-D]嘧啶-1-基]-2-甲基丙基]-4-吡啶甲酰胺 |
1354825-58-3 |
详细
|
| Dp44mT |
2-(二-2-吡啶基亚甲基)-N,N-二甲基肼基硫代甲酰胺 |
152095-12-0 |
详细
|
| Didesmethylrocaglamide |
DIDESMETHYLROCAGLAMIDE |
177262-30-5 |
详细
|
| Hemin |
氯化血红素 |
16009-13-5 |
详细
|
| Pralnacasan |
化合物 T16570 |
192755-52-5 |
详细
|
| DCVC |
S-[(1E)-1;2-DICHLOROETHENYL]--L-CYSTEINE |
13419-46-0 |
详细
|
| SID 3712249 |
522606-67-3 |
522606-67-3 |
详细
|
| EPZ004777 |
EPZ004777 |
1338466-77-5 |
详细
|
| Xevinapant |
AT-406 |
1071992-99-8 |
详细
|
| (S)-Gossypol acetic acid |
1189561-66-7 |
1189561-66-7 |
详细
|
| TC-DAPK 6 |
TC-DAPK 6 |
315694-89-4 |
详细
|
| kb NB 142-70 |
3,4-二氢-9-羟基-[1]苯并噻吩并[2,3-F]-1,4-硫氮杂卓-5(2H)-酮 |
1233533-04-4 |
详细
|
| WEHI-539 hydrochloride |
2070018-33-4 |
2070018-33-4 |
详细
|
| MPTP hydrochloride |
1-甲基-4-苯基-1,2,3,6-四氢吡啶盐酸盐 |
23007-85-4 |
详细
|
| GSK-J4 |
N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸乙酯 |
1373423-53-0 |
详细
|
| CRT0066101 dihydrochloride |
CS-2578 |
1883545-60-5 |
详细
|
| CUDC-427 |
1446182-94-0 |
1446182-94-0 |
详细
|
| MIR96-IN-1 |
1311982-88-3 |
1311982-88-3 |
详细
|
| Targapremir-210 |
TARGAPREMIR-210 |
1049722-30-6 |
详细
|
| Mdivi-1 |
3-(2,4-二氯-5-甲氧基苯基)-2,3-二氢-2-硫代-4(1H)-喹唑啉酮 |
338967-87-6 |
详细
|
| Domatinostat tosylate |
4SC-202(盐的形式) |
1186222-89-8 |
详细
|
| Mcl1-IN-2 |
7-[(2-吡啶基氨基)-2-噻吩基甲基]-8-喹啉醇 |
292057-76-2 |
详细
|
| PK68 |
PK68 |
2173556-69-7 |
详细
|
| UC-112 |
5-[(苯基甲氧基)甲基]-7-(1-吡咯烷基甲基)-8-喹啉醇 |
383392-66-3 |
详细
|
| Minerval |
2-羟基乳清酸 |
56472-29-8 |
详细
|
| MYCi361 |
MYCI361 |
2289690-31-7 |
详细
|
| Bromelain |
菠萝蛋白酶 |
9001-00-7 |
详细
|
| MCL-1/BCL-2-IN-2 |
MCL-1/BCL-2-IN-2 |
2163793-44-8 |
详细
|
| MCL-1/BCL-2-IN-3 |
MCL-1/BCL-2-IN-3 |
2163793-55-1 |
详细
|
| SR-4835 |
SR-4835 |
2387704-62-1 |
详细
|
| MDM2-IN-1 |
MDM2-IN-1 |
1410737-09-5 |
详细
|
| Bz 423 |
216691-95-1 |
216691-95-1 |
详细
|
| BOC-D-FMK |
3-[[叔丁氧羰基]氨基]-5-氟-4-氧代戊酸甲酯 |
634911-80-1 |
详细
|
| Silvestrol |
(1R,2R,3S,3AR,8BS)-6-[[(2S,3R,6R)-6-[(1R)-1,2-二羟基乙基]-3-甲氧基-1,4-二氧己环-2-基]氧基]-2,3,3A,8B-四氢-1,8B-二羟基-8-甲氧基-3A-(4-甲氧基苯基)-3-苯基-1H-环戊烯并[B]苯并呋喃-2-羧酸甲酯 |
697235-38-4 |
详细
|
| AR-42 |
AR-42 |
935881-37-1 |
详细
|
| Tubastatin A Hydrochloride |
Tubastatin A盐酸盐 |
1310693-92-5 |
详细
|
| Tubastatin A |
TUBASTATIN A |
1252003-15-8 |
详细
|
| Eribulin |
甲磺酸艾日布林 |
253128-41-5 |
详细
|
| Eribulin mesylate |
甲磺酸艾日布林 |
441045-17-6 |
详细
|
| PAC-1 |
PAC1 |
315183-21-2 |
详细
|
| Gemcitabine (elaidate) |
吉西他滨反油酸酯 |
210829-30-4 |
详细
|
| Batabulin |
Unii-T4np8G3K6q |
195533-53-0 |
详细
|
| Batabulin sodium |
T67 |
195533-98-3 |
详细
|
| Bendamustine |
宾达氮芥 |
16506-27-7 |
详细
|
| Necroptosis-IN-1 |
5-(7-Chloro-1H-indol-3-ylMethyl)-iMidazolidine-2,4-dione |
1391980-92-9 |
详细
|
| Piclidenoson |
IB-MECA |
152918-18-8 |
详细
|
| CDDO-3P-Im |
CPD1589 |
1883650-95-0 |
详细
|
| Cladribine |
克拉屈滨 |
4291-63-8 |
详细
|
| Estramustine phosphate sodium |
雌莫司汀磷酸钠 |
52205-73-9 |
详细
|
| RA-9 |
(3E,5E)-3,5-双(4-硝基亚苄基)哌啶-4-酮 |
919091-63-7 |
详细
|
| LQZ-7I |
N2,N3-双(4-氟苯基)喹喔啉-2,3-二胺 |
195822-23-2 |
详细
|
| BCL6-IN-5 |
BCL6-IN-5 |
2253878-09-8 |
详细
|
| Meisoindigo |
甲异靛 |
97207-47-1 |
详细
|
| Mitotane |
米托坦 |
53-19-0 |
详细
|
| Pemetrexed disodium hemipenta hydrate |
培美曲塞二钠2.5水合物 |
357166-30-4 |
详细
|
| MK-8745 |
MK8745 |
885325-71-3 |
详细
|
| PD0166285 |
6-(2,6-二氯苯基)-2-[[4-[2-(二乙基氨基)乙氧基]苯基]氨基]-8-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮 |
185039-89-8 |
详细
|
| Pioglitazone D4 |
匹格列酮-D4 |
1134163-29-3 |
详细
|
| b-AP15 |
b-AP15 |
1009817-63-3 |
详细
|
| YK-4-279 |
YK 4-279 |
1037184-44-3 |
详细
|
| Lometrexol |
洛美曲索 |
106400-81-1 |
详细
|
| Lometrexol hydrate |
洛美曲索水合物 |
1435784-14-7 |
详细
|
| Pioglitazone hydrochloride |
盐酸吡格列酮 |
112529-15-4 |
详细
|
| Necrostatin 2 |
(5R)-5-[(7-氯-1H-吲哚-3-基)甲基]-3-甲基-2,4-咪唑烷二酮 |
852391-19-6 |
详细
|
| Necrostatin 2 S enantiomer |
(5S)-5-[(7-氯-1H-吲哚-3-基)甲基]-3-甲基-2,4-咪唑烷二酮 |
852391-20-9 |
详细
|
| NSC-207895 |
4-(4-甲基-1-哌嗪基)-7-硝基-2,1,3-苯并二唑 3-氧化物 |
58131-57-0 |
详细
|
| Tasisulam |
他斯索兰 |
519055-62-0 |
详细
|
| Verubulin |
(4-甲氧基苯基)(甲基)(2-甲基喹唑啉-4-基)胺 |
827031-83-4 |
详细
|
| NSC 66811 |
7-(ALPHA-苯胺基苄基)-2-甲基-8-喹啉醇 |
6964-62-1 |
详细
|
| L-Theanine |
L-茶氨酸 |
3081-61-6 |
详细
|
| MI-3 |
MI-3 (Menin-MLL Inhibitor) |
1271738-59-0 |
详细
|